1,588
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer

, , , , , , , & show all
Article: e1310359 | Received 09 Jan 2017, Accepted 19 Mar 2017, Published online: 08 May 2017

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65:5-29; PMID:25559415; https://doi.org/10.3322/caac.21254
  • Field JK, Duffy SW. Lung cancer screening: The way forward. Br J Cancer 2008; 99:557-62; PMID:18665179; https://doi.org/10.1038/sj.bjc.6604509
  • Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL. CT screening for lung cancer: Five-year prospective experience. Radiology 2005; 235:259-65; PMID:15695622; https://doi.org/10.1148/radiol.2351041662
  • Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, Hasegawa M, Yamanda T, Kubo K, Hanamura K et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351:1242-5; PMID:9643744; https://doi.org/10.1016/S0140-6736(97)08229-9
  • National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. The N Engl J Med 2011; 365:395-409; PMID:21714641; https://doi.org/10.1056/NEJMoa1102873
  • Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169:2071-7; PMID:20008689; https://doi.org/10.1001/archinternmed.2009.440
  • Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001; 84:25-32; PMID:11139308; https://doi.org/10.1054/bjoc.2000.1531
  • Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001; 108:1411-5; PMID:11714730; https://doi.org/10.1172/JCI14451
  • Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: Reporters from the immune system. Immunol Rev 2008; 222:328-40; PMID:18364012; https://doi.org/10.1111/j.1600-065X.2008.00611.x
  • Dai L, Lei N, Liu M, Zhang JY. Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC). Exp Hematol Oncol 2013; 2:15; PMID:23687996; https://doi.org/10.1186/2162-3619-2-15
  • Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein C et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008; 26:5060-6; PMID:18794547; https://doi.org/10.1200/JCO.2008.16.2388
  • Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers–blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 2011; 8:142-50; PMID:21364687; https://doi.org/10.1038/nrclinonc.2010.220
  • Desmetz C, Mange A, Maudelonde T, Solassol J. Autoantibody signatures: Progress and perspectives for early cancer detection. J Cell Mol Med 2011; 15:2013-24; PMID:21651719; https://doi.org/10.1111/j.1582-4934.2011.01355.x
  • Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Tureci O, Wiewrodt R, Barnes AC, Robertson JF. Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax 2008; 63:228-33; PMID:17932110; https://doi.org/10.1136/thx.2007.083592
  • Khattar NH, Coe-Atkinson SP, Stromberg AJ, Jett JR, Hirschowitz EA. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther 2010; 10:267-72; PMID:20543565; https://doi.org/10.4161/cbt.10.3.12395
  • Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF et al. EarlyCDT-Lung: An immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res 2011; 4:1126-34; PMID:21733826; https://doi.org/10.1158/1940-6207.CAPR-10-0328
  • Greenberg AK, Lu F, Goldberg JD, Eylers E, Tsay JC, Yie TA, Naidich D, McGuinness G, Pass H, Tchou-Wong KM et al. CT scan screening for lung cancer: Risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One 2012; 7:e39403; PMID:22768300; https://doi.org/10.1371/journal.pone.0039403
  • Rom WN, Goldberg JD, Addrizzo-Harris D, Watson HN, Khilkin M, Greenberg AK, Naidich DP, Crawford B, Eylers E, Liu D et al. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer 2010; 10:234; PMID:20504322; https://doi.org/10.1186/1471-2407-10-234
  • Patel K, Farlow EC, Kim AW, Lee BS, Basu S, Coon JS, DeCresce D, Thimothy L, Walters KA, Fhied C et al. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Int J Cancer 2011; 129:133-42; PMID:20824709; https://doi.org/10.1002/ijc.25644
  • Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Toda T, Terai S, Sakaida I, Oka M, Nakamura K, Okita K. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004; 4:2111-6; PMID:15221772; https://doi.org/10.1002/pmic.200300712
  • Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang KT, Ito H, Inoue T, Oshimura M. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 2005; 5:3205-13; PMID:16003825; https://doi.org/10.1002/pmic.200401307
  • Vallat L, Magdelenat H, Merle-Beral H, Masdehors P, Potocki de Montalk G, Davi F, Kruhoffer M, Sabatier L, Orntoft TF, Delic J. The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood 2003; 101:4598-606; PMID:12586635; https://doi.org/10.1182/blood-2002-06-1743
  • Zhang J, Song M, Wang J, Sun M, Wang B, Li R, Huang Y, Hou L, Jin Y, Wang M et al. Enoyl coenzyme A hydratase 1 is an important factor in the lymphatic metastasis of tumors. Biomed Pharmacother 2011; 65:157-62; PMID:21616630; https://doi.org/10.1016/j.biopha.2011.02.010
  • Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994; 13:5483-95; PMID:7957114.
  • Abdul-Manan N, Williams KR. hnRNP A1 binds promiscuously to oligoribonucleotides: Utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res 1996; 24:4063-70; PMID:8918813; https://doi.org/10.1093/nar/24.20.4063
  • Munro TP, Magee RJ, Kidd GJ, Carson JH, Barbarese E, Smith LM, Smith R. Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem 1999; 274:34389-95; PMID:10567417; https://doi.org/10.1074/jbc.274.48.34389
  • Hamilton BJ, Nagy E, Malter JS, Arrick BA, Rigby WF. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem 1993; 268:8881-7; PMID:8473331
  • Siveke JT. The increasing diversity of KRAS signaling in pancreatic cancer. Gastroenterology 2014; 147:736-9; PMID:25167989; https://doi.org/10.1053/j.gastro.2014.08.026
  • Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li ZH, Liu XD, Wang SG, Bie P, Jiang P et al. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis 2011; 32:1419-26; PMID:21642356; https://doi.org/10.1093/carcin/bgr088
  • Stockley J, Villasevil ME, Nixon C, Ahmad I, Leung HY, Rajan P. The RNA-binding protein hnRNPA2 regulates beta-catenin protein expression and is overexpressed in prostate cancer. RNA Biol 2014; 11:755-65; PMID:24823909; https://doi.org/10.4161/rna.28800
  • Shilo A, Ben Hur V, Denichenko P, Stein I, Pikarsky E, Rauch J, Kolch W, Zender L, Karni R. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA 2014; 20:505-15; PMID:24572810; https://doi.org/10.1261/rna.042259.113
  • Tauler J, Zudaire E, Liu H, Shih J, Mulshine JL. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res 2010; 70:7137-47; PMID:20807810; https://doi.org/10.1158/0008-5472.CAN-10-0860
  • Jing GJ, Xu DH, Shi SL, Li QF, Wang SY, Wu FY, Kong HY. Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma. J Gastroenterol Hepatol 2011; 26:108-15; PMID:21175803; https://doi.org/10.1111/j.1440-1746.2010.06482.x
  • Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C, Guialis A. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: Parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer 2010; 10:434; PMID:20716340; https://doi.org/10.1186/1471-2407-10-434
  • Cui H, Wu F, Sun Y, Fan G, Wang Q. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC Cancer 2010; 10:356; PMID:20604928; https://doi.org/10.1186/1471-2407-10-356
  • Huguet S, Labas V, Duclos-Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E. Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics 2004; 4:1341-5; PMID:15188401; https://doi.org/10.1002/pmic.200300757
  • Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer 2016; 99:172-9; PMID:27565936; https://doi.org/10.1016/j.lungcan.2016.07.018
  • Vase MO, Friis S, Bautz A, Bendix K, Sorensen HT, d'Amore F. Breast implants and anaplastic large-cell lymphoma: A danish population-based cohort study. Cancer Epidemiol Biomarkers Prev 2013; 22:2126-9; PMID:23956025; https://doi.org/10.1158/1055-9965.EPI-13-0633
  • Chen H, Werner S, Tao S, Zornig I, Brenner H. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Cancer Lett 2014; 346:178-87; PMID:24462820; https://doi.org/10.1016/j.canlet.2014.01.007
  • Werner S, Chen H, Tao S, Brenner H. Systematic review: Serum autoantibodies in the early detection of gastric cancer. Int J Cancer 2015; 136:2243-52; PMID:24615018; https://doi.org/10.1002/ijc.28807
  • Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using serological proteome analysis to identify serum anti-nucleophosmin 1 autoantibody as a potential biomarker in European-American and African-American patients with prostate cancer. Prostate 2016; 76:1375-86; PMID:27418398; https://doi.org/10.1002/pros.23217

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.